Lodewyk F A Wessels Selected Research

Lodewyk F A Wessels Research Topics

Disease

70	Neoplasms (Cancer) 05/2022 - 05/2005
34	Breast Neoplasms (Breast Cancer) 05/2022 - 05/2005
7	Colonic Neoplasms (Colon Cancer) 02/2021 - 11/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2015
5	Colorectal Neoplasms (Colorectal Cancer) 02/2020 - 02/2014
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2006
4	Squamous Cell Carcinoma of Head and Neck 03/2019 - 02/2005
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 07/2011
3	Carcinoma (Carcinomatosis) 03/2019 - 07/2007
3	Triple Negative Breast Neoplasms 01/2019 - 10/2015
2	Inflammation (Inflammations) 01/2019 - 01/2019
2	Hypersensitivity (Allergy) 04/2018 - 05/2014
1	Tertiary Lymphoid Structures 01/2021
1	Lobular Carcinoma 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Pathologic Complete Response 01/2018
1	Endometrial Neoplasms (Endometrial Cancer) 01/2017
1	Genetic Translocation (Chromosomal Translocation) 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 10/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2015
1	Melanoma (Melanoma, Malignant) 04/2014
1	Microsatellite Instability 02/2014

Drug/Important Bio-Agent (IBA)

18	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
12	Pharmaceutical PreparationsIBA 01/2022 - 11/2012
11	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2014
8	Estrogen ReceptorsIBA 01/2020 - 07/2007
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021 - 11/2012
7	Tamoxifen FDA LinkGeneric 01/2020 - 01/2009
6	Messenger RNA (mRNA)IBA 03/2022 - 01/2010
5	RNA (Ribonucleic Acid)IBA 05/2022 - 02/2010
5	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 11/2015
5	Phosphotransferases (Kinase)IBA 02/2020 - 11/2012
5	ChromatinIBA 01/2018 - 04/2014
4	Biological ProductsIBA 01/2022 - 02/2014
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 05/2005
3	Transcription Factors (Transcription Factor)IBA 02/2020 - 03/2013
3	PlatinumIBA 03/2019 - 06/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015 - 05/2005
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2021 - 01/2020
2	Hormones (Hormone)IBA 02/2020 - 01/2016
2	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2020 - 11/2016
2	LigandsIBA 01/2019 - 10/2018
2	Estrogens (Estrogen)FDA Link 03/2017 - 01/2017
2	Small Interfering RNA (siRNA)IBA 03/2017 - 04/2014
2	Histones (Histone)IBA 01/2017 - 07/2015
2	Trastuzumab (Herceptin)FDA Link 11/2016 - 01/2016
2	Formaldehyde (Formol)FDA Link 03/2016 - 02/2011
2	Phenobarbital (Luminal)FDA Link 07/2014 - 01/2010
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2014 - 06/2013
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 11/2012
2	MicroRNAs (MicroRNA)IBA 01/2014 - 07/2011
1	AndrogensIBA 01/2022
1	enzalutamideIBA 01/2022
1	TransactIBA 12/2021
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2021
1	SenotherapeuticsIBA 01/2021
1	NivolumabIBA 12/2020
1	IpilimumabIBA 12/2020
1	tyrosine receptor (receptor, tyrosine)IBA 02/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020
1	EndonucleasesIBA 01/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Glycoside Hydrolases (Endoglycosidases)IBA 11/2018
1	Poly Adenosine Diphosphate RiboseIBA 11/2018
1	AZD4547IBA 10/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2018
1	A 19IBA 04/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	neratinibIBA 01/2018
1	Everolimus FDA Link 08/2017
1	Cadherins (E-Cadherin)IBA 08/2017
1	Epidermal Growth Factor (EGF)IBA 03/2017
1	Lysine (L-Lysine)FDA Link 01/2017
1	MK 2206IBA 11/2016
1	GSK-2816126IBA 10/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2016
1	Cytidine DeaminaseIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 10/2015
1	HeterochromatinIBA 07/2015
1	AclarubicinIBA 07/2015
1	AnthracyclinesIBA 07/2015
1	Alkylating AgentsIBA 05/2014
1	Carboplatin (JM8)FDA LinkGeneric 05/2014
1	SaltsIBA 05/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2014
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 04/2014
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 04/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2014

Therapy/Procedure

21	Therapeutics 03/2022 - 01/2006
14	Drug Therapy (Chemotherapy) 05/2022 - 05/2005
6	Neoadjuvant Therapy 05/2022 - 05/2005
2	Segmental Mastectomy (Lumpectomy) 12/2021 - 03/2021
2	Aftercare (After-Treatment) 01/2021 - 05/2005
2	Chemoradiotherapy 03/2019 - 01/2018
1	Immunotherapy 01/2021